Hervé Bard Selected Research

Viscosupplementation

12/2021	Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical Practice.
1/2021	Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group.
1/2020	EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation.
1/2020	EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis.
1/2018	Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO).
10/2015	Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hervé Bard Research Topics

Disease

6	Knee Osteoarthritis 12/2021 - 10/2007
6	Osteoarthritis 01/2021 - 05/2012
2	Pain (Aches) 01/2020 - 01/2018
1	Overweight 01/2020
1	Disease Progression 01/2018

Drug/Important Bio-Agent (IBA)

6	Hyaluronic Acid (Hyaluronan)IBA 12/2021 - 10/2007
1	ViscosupplementsIBA 05/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2012

Therapy/Procedure

6	Viscosupplementation 12/2021 - 10/2015
2	Retreatment 12/2021 - 01/2018
2	Injections 10/2021 - 10/2021
2	Intra-Articular Injections 10/2021 - 05/2012
2	Therapeutics 01/2020 - 10/2007
1	Contraindications 01/2020